SereNeuro Therapeutics
Biotechnology Research • 
Baltimore, Maryland, United States • 1-10 Employees
Company overview
| Headquarters | Baltimore, Maryland, United States |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
| Socials |
Key Contact at SereNeuro Therapeutics
Daniel Saragnese
CEO, Co-Founder
About SereNeuro Therapeutics
SereNeuro Therapeutics is developing breakthrough non-opioid advanced therapy treatments for pain at scale.
$
SereNeuro Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
SereNeuro Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Switzerland
Israel
United Kingdom
Frequently asked questions
SereNeuro Therapeutics is located in Baltimore, Maryland, US.
SereNeuro Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
SereNeuro Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
